Recent News

May 20, 2021

News Scan for May 20, 2021

Pneumococcal vaccine and kids' antibiotics
Expert panel on zoonotic diseases
CWD expands in Virginia
Final ground turkey Salmonella update
May 14, 2021

News Scan for May 14, 2021

COVID campus safety ideas
Prepandemic adult vaccination
Vaccine-linked polio in 4 countries
Apr 23, 2021

News Scan for Apr 23, 2021

Malaria vaccine trial
Bacterial coinfections in flu patients
Vegan cheese Salmonella outbreak
Mar 12, 2021
Sick girl in bed with dad taking her temperature

Randomized trial supports shorter antibiotic course for kids' pneumonia

"We should work toward improving care for our patients with right-sized antibiotic courses."

Mar 01, 2021

Stewardship / Resistance Scan for Mar 01, 2021

CARB-X funds for vaccines
VA sputum susceptibility
Oct 20, 2020

Stewardship / Resistance Scan for Oct 20, 2020

VA antibiotic use during COVID-19
Shorter pneumonia therapy
Oct 13, 2020
Antibiotic-resistant superbugs

Phase 3 trials show positive results for cefiderocol, but questions remain

Two studies show the new antibiotic is safe and effective for difficult-to-treat MDR infections.

Jul 29, 2020

News Scan for Jul 29, 2020

New DRC Ebola case
Pneumococcal vaccine and heart attacks
H5N6 avian flu in the Philippines
Jun 11, 2020

News Scan for Jun 11, 2020

Antibiotics for kids' pneumonia
Northward spread of Heartland virus ticks
Legionnaires' disease and toilets
Apr 30, 2020
Childhood vaccination

Study highlights impact of childhood vaccines on antibiotic use

The study provides clear evidence of the power of childhood vaccines on reducing the antibiotic resistance burden.

Resources & Literature

Recent Literature

Africano HF, Serrano-Mayorga CC, Ramirez-Valbuena PC, et al. Major adverse cardiovascular events during invasive pneumococcal disease are serotype dependent. Clin Infect Dis 2020 (published online Sep 22)

Agudelo CI, Castaneda-Orjuela C, Brandileone MC, et al. The direct effect of pneumococcal conjugate vaccines on invasive pneumococcal disease in children in the Latin American and Caribbean region (SIREVA 2006–17): a multicentre, retrospective observational study. Lancet Infect Dis 2020 (published online Sep 25)

Albin OR, Kaye KS. Utility of radiographic keyword abstraction for identification of misdiagnosed pneumonia. Infect Control Hosp Epidemiol 2021 (Concise communication) (published online Apr 29)

Appelt S, Jacob D, Rohleder AM, et al. Assessment of biorisk management systems in high containment laboratories, 18 countries in Europe, 2016 and 2017. Eurosurveill 2020 Sep 10;26(36)

Arias-Fernandez L, Gil-Prieto R, Gil-de-Miguel A. Incidence, mortality, and lethality of hospitalizations for community-acquired pneumonia with comorbid cardiovascular disease in Spain (1997–2015). BMC Infect Dis 2020 (published online Jul 6)

Aris P, Robatjazi S, Nikkhahi F, et al. Molecular mechanisms and prevalence of colistin resistance of Klebsiella pneumoniae in the Middle East region: a review over five last years. J Glob Antimicrob Resist 2020 (published online Jun 23)

Baron SA, Cassir N, Hamel M, et al. Risk factors for acquisition of colistin-resistant Klebsiella pneumoniae and expansion of a colistin-resistant ST307 epidemic clone in hospitals in Marseille, France, 2014 to 2017. Eurosurveill 2021 May 27;26(21)

Bartley PS, Deshpande A, Yu PC, et al. Bacterial coinfection in influenza pneumonia: Rates, pathogens, and outcomes. Infect Control Hosp Epidemiol 2021 (published online Apr 23)

Beall B, Walker H, Tran T, et al. Upsurge of conjugate vaccine serotype 4 invasive pneumococcal disease clusters among adults experiencing homelessness in California, Colorado, and New Mexico. J Infect Dis 2020 (published online Aug 15)

Ben-Shimol S, Givon-Lavi N, Kotler L, et al. Post–13-valent pneumococcal conjugate vaccine dynamics in young children of serotypes included in candidate extended-spectrum conjugate vaccines. Emerg Infect Dis 2021 Jan;27(1)

Berry I, Tuite AR, Salomon A, et al. Association of influenza activity and environmental conditions with the risk of invasive pneumococcal disease. JAMA Netw Open 2020 Jul 13;3(7):e2010167

Camara J, Grau I, Gonzalez-Diaz A, et al. A historical perspective of MDR invasive pneumococcal disease in Spanish adults. J Antimicrob Chemother 2020 (published online Nov 30)

Cao T, Liu Y, Li Y, et al. A public health concern: emergence of carbapenem-resistant Klebsiella pneumoniae in a public transportation environment. J Antimicrob Chemother 2020 (published online Jul 4)

Carey E, Blankenhorn R, Chen P, et al. Non-ventilator associated hospital acquired pneumonia incidence and health outcomes among U.S. veterans from 2016-2020. Am J Infect Control 2021 (published online Jun 8)

Carr OJ, Vilivong K, Bounvilay L, et al. Nasopharyngeal pneumococcal colonization Density is associated with severe pneumonia in young children in the Lao PDR. J Infect Dis 2021 (published online May 11)

Chan T, Tay MZ, Kyaw WM, et al. Epidemiology, vaccine effectiveness, and risk factors for mortality for pneumococcal disease among hospitalised adults in Singapore: a case-control study. BMC Infect Dis 2020 Jun 17;20 (423)

Chapman R, Sutton K, Dillon-Murphy D, et al. Ten year public health impact of 13-valent pneumococcal conjugate vaccination in infants: a modelling analysis. Vaccine 2020 (published online Sep 8)

Chen D, Ye Z, Pi Z, et al. Cost-effectiveness of dual influenza and pneumococcal vaccination among the elderly in Shenzhen, China. Vaccine 2021 (published online Mar 20)

Chen FJ, Lauderdale TL, Huang WC, et al. Emergence of mcr-1, mcr-3, and mcr-8 in clinical Klebsiella pneumoniae isolates in Taiwan. Clin Microbiol Infect 2020 (published online Aug 6)

Chen H, Matsumoto H, Horita N, et al. Prognostic factors for mortality in invasive pneumococcal disease in adult: a system review and meta-analysis. Sci Rep 2021 Jun4;11:11865

Chen IR, Huanag PH, Wu PF, et al. Clinical characteristics and outcomes of 56 patients with pneumonia caused by carbapenem-resistant Klebsiella pneumoniae. J Glob Antimicrob Resist 2021 (published online May 4)

Chen L, Han X, Li YL, et al. The impact of early neuraminidase inhibitor therapy on clinical outcomes in patients hospitalised with influenza A-related pneumonia: a multicenter, retrospective study. BMC Infect Dis 2020 Aug 26;20(628)

Chen YC, Hsu WY, Chang TH. Macrolide-resistant Mycoplasma pneumoniae infections in pediatric community-acquired pneumonia. Emerg Infect Dis 2020 Jul;26(7)

Chen Z, Wu H, Jiang J, et al. Nutritional risk screening score as an independent predictor of nonventilator hospital-acquired pneumonia: a cohort study of 67,280 patients. BMC Infect Dis 2021 Apr 1;21:313

Clarke E, Bashorun A, Adigweme I, et al. Immunogenicity and safety of a novel ten-valent pneumococcal conjugate vaccine in healthy infants in the Gambia: a phase 3, randomised, double-blind, non-inferiority trial. Lancet Infect Dis 2021 (published Jan 28)

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»


Unrestricted financial support provided by

Bentson FoundationUnorthodox Philanthropy logo and text 'Leading Underwriter'3M logoGilead Become an underwriter»